Novel insights on perils and promises of miRNA in understanding colon cancer metastasis and progression

Colorectal cancer (CRC) is the third highest frequent malignancy and ultimate critical source of cancer-associated mortality around the world. Regardless of latest advances in molecular and surgical targeted medicines that have increased remedial effects in CRC patients, the 5-year mortality rate fo...

Full description

Saved in:
Bibliographic Details
Published in:Medical oncology (Northwood, London, England) London, England), 2023-08, Vol.40 (10), p.282-282, Article 282
Main Authors: Tariq, Lubna, Arafah, Azher, Sehar, Nouroz, Ali, Aarif, Khan, Andleeb, Rasool, Iyman, Rashid, Shahzada Mudasir, Ahmad, Sheikh Bilal, Beigh, Saba, Dar, Tanveer Ul Hassan, Rehman, Muneeb U.
Format: Article
Language:English
Subjects:
Cancer
Cell cycle
Colorectal cancer
Hematology
Internal Medicine
Medicine
Medicine & Public Health
MicroRNAs
Oncology
Pathology
Review Article
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Colorectal cancer (CRC) is the third highest frequent malignancy and ultimate critical source of cancer-associated mortality around the world. Regardless of latest advances in molecular and surgical targeted medicines that have increased remedial effects in CRC patients, the 5-year mortality rate for CRC patients remains dismally low. Evidence suggests that microRNAs (miRNAs) execute an essential part in the development and spread of CRC. The miRNAs are a type of short non-coding RNA that exhibited to control the appearance of tumor suppressor genes and oncogenes. miRNA expression profiling is already being utilized in clinical practice as analytical and prognostic biomarkers to evaluate cancer patients' tumor genesis, advancement, and counteraction to drugs. By modulating their target genes, dysregulated miRNAs are linked to malignant characteristics (e.g., improved proliferative and invasive capabilities, cell cycle aberration, evasion of apoptosis, and promotion of angiogenesis). This review presents an updated summary of circulatory miRNAs, tumor-suppressive and oncogenic miRNAs, and the potential reasons for dysregulated miRNAs in CRC. Further we will explore the critical role of miRNAs in CRC drug resistance.
ISSN:1559-131X
1357-0560
1559-131X
DOI:10.1007/s12032-023-02099-2